Journal Title：European Journal Of Clinical Investigation

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考慮從最復雜的基礎分子科學到廣泛分支學科的應用臨床和轉化研究以及循證醫(yī)學的任何原創(chuàng)貢獻。EJCI 發(fā)表與人類生物學和疾病的遺傳、分子、細胞或生理基礎有關的高質(zhì)量研究報告，以及涉及疾病的流行、診斷、過程、治療和預防的研究。我們主要對與人類直接相關的研究感興趣，但也鼓勵提交可靠的體外和動物研究。該期刊非常重視使用創(chuàng)新方法以及實驗室、臨床和流行病學方法和技術組合的跨學科工作和研究。幾類稿件（詳細描述見下文）將被考慮：社論、原創(chuàng)文章（還包括隨機臨床試驗、系統(tǒng)評價和薈萃分析）、評論（敘述性評論）、意見文章（包括辯論、觀點和評論）；以及致編輯的信。

European Journal Of Clinical Investigation創(chuàng)刊于1970年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 醫(yī)學：內(nèi)科全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約1月 ，影響因子指數(shù)4.4，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。